NeuN immunofluorescence detection on frozen sections of mouse brain showed that CLMD significantly reduced the loss of neurons in the CA1 and CA3 regions of the hippocampus in CKD mice. This evidence concerns the gene RBFOX3 and chronic kidney disease.